BioSpace News Archive

Business

CardioFocus Announces Expanded Partnership With Japan Lifeline

The expanded partnership solidifies the commercial strategy for bringing the HeartLight Endoscopic Ablation System to the Japanese market.

January 9, 2018
·
3 min read
Business

Bayer and VETTED Join Forces to Help U.S. Veterans Transition to the Workforce

In an effort to help veterans excel in civilian life, Bayer and VETTED today unveiled a new partnership in which Bayer will serve as title sponsor of VAMP at the University of Texas and Texas A&M University.

January 9, 2018
·
4 min read
Biotech Bay

Gynesonics Announces Results from Pivotal IDE Trial for Incision Free Treatment for Uterine Fibroids

The FDA specified co-primary endpoints were reduction of bleeding and freedom from surgical reintervention due to HMB, both at 12-month follow-up.

January 9, 2018
·
4 min read
Policy

Sonoma Pharmaceuticals Receives Three New United Arab Emirates Regulatory Approvals: Acuicyn for Management of Blepharitis, Microsafe Oral Care for Mucositis and Sinudox for Chronic Sinusitis

The first approval is for Acuicyn eyelid and eyelash hygiene, an antimicrobial solution (hypochlorous acid) indicated to treat symptoms and causes of blepharitis on the eyelid and eyelash.

January 9, 2018
·
6 min read
Bedfont Hits the Ground Running in 2018 as it’s Named in Europe’s ‘Ones to Watch’ List

edfont, a second-generation family business that specialises in the design and manufacture of breath analysis medical devices, is proud to announce that it has been named on this list as one of Europe’s best.

January 9, 2018
·
1 min read
Drug Development

Ziopharm Oncology Provides Update on Standout Technologies During the 36th Annual J.P. Morgan Healthcare Conference

The Company’s corporate presentation at the J.P. Morgan conference is Thursday, Jan. 11, at 10 a.m. PST. T

January 9, 2018
·
9 min read
Drug Development

FDA Clears Pluristem’s Expanded Access Program to Initiate Treatments of Critical Limb Ischemia Outside of Ongoing Phase III Study

The Company’s PLX-PAD program has already been selected for accelerated approval pathways in both regions, including the FDA’s Fast Track Designation and the EMA Adaptive Pathways program.

January 9, 2018
·
5 min read
Drug Development

Incysus Submits Second Investigational New Drug Application for Gamma-Delta T Cell Immunotherapy Candidate

IND to support Phase 1 safety and activity study of Drug Resistant Immunotherapy for the treatment of glioblastoma.

January 9, 2018
·
2 min read
Business

Inovio Pharmaceuticals and the Parker Institute for Cancer Immunotherapy Establish Clinical Development Collaboration To Evaluate Novel Cancer Immunotherapy Combinations

The initial trial under consideration between Inovio and the Parker Institute would address muscle invasive bladder cancer with INO-5401 in combination with checkpoint inhibitors and immune modulators.

January 9, 2018
·
8 min read
Zora Expands CERT - A Validated Test for Cardiovascular and Diabetes Risk Prediction

Zora Biosciences Oy has announced the expansion of its CERT to include prediction of type II diabetes.

January 9, 2018
·
2 min read